Lisata Therapeutics (LSTA) Assets Average (2016 - 2025)
Lisata Therapeutics (LSTA) has disclosed Assets Average for 11 consecutive years, with $23.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Assets Average fell 41.91% year-over-year to $23.5 million, compared with a TTM value of $23.5 million through Sep 2025, down 41.91%, and an annual FY2024 reading of $44.8 million, changed N/A over the prior year.
- Assets Average was $23.5 million for Q3 2025 at Lisata Therapeutics, down from $27.1 million in the prior quarter.
- Across five years, Assets Average topped out at $64.3 million in Q2 2023 and bottomed at $23.5 million in Q3 2025.
- Average Assets Average over 3 years is $44.9 million, with a median of $45.4 million recorded in 2024.
- The sharpest move saw Assets Average dropped 9.85% in 2024, then tumbled 41.91% in 2025.
- Year by year, Assets Average stood at $56.4 million in 2023, then plummeted by 35.1% to $36.6 million in 2024, then plummeted by 35.9% to $23.5 million in 2025.
- Business Quant data shows Assets Average for LSTA at $23.5 million in Q3 2025, $27.1 million in Q2 2025, and $32.0 million in Q1 2025.